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Supplementary Figure-1-Partridge. Genomic engineering of 
the fly tau locus 
a 
GAATTCAGTTTATTTTTAAAATTTAACTATCTCAATATGATTCATGATATATCCATCCATGCCTCCCTCATGTATCTTTTGGTTTATTTCAGAGAT
GGCTGAGCCCCGCCAGGAGTTCGAAGTGATGGAAGATCACGCTGGGACGTACGGGTTGGGGGACAGGAAAGATCAGGGGGGCTAC
ACCATGCACCAAGACCAAGAGGGTGACACGGACGCTGGCCTGAAAGAATCTCCCCTGCAGACCCCCACTGAGGACGGATCTGAGGA
ACCGGGCTCTGAAACCTCTGATGCTAAGAGCACTCCAACAGCGGAAGATGTGACAGCACCCTTAGTGGATGAGGGAGCTCCCGGCA
AGCAGGCTGCCGCGCAGCCCCACACGGAGATCCCAGAAGGAACCACAGCTGAAGAAGCAGGCATTGGAGACACCCCCAGCCTGGA
AGACGAAGCTGCTGGTCACGTGACCCAAGCTCGCATGGTCAGTAAAAGCAAAGACGGGACTGGAAGCGATGACAAAAAAGCCAAG
GGGGCTGATGGTAAAACGAAGATCGCCACACCGCGGGGAGCAGCCCCTCCAGGCCAGAAGGGCCAGGCCAACGCCACCAGGATTC
CAGCAAAAACCCCGCCCGCTCCAAAGACACCACCCAGCTCTGGTGAACCTCCAAAATCAGGGGATCGCAGCGGCTACAGCAGCCCC
GGCTCCCCAGGCACTCCCGGCAGCCGCTCCCGCACCCCGTCCCTTCCAACCCCACCCACCCGGGAGCCCAAGAAGGTGGCAGTGG
TCCGTACTCCACCCAAGTCGCCGTCTTCCGCCAAGAGCCGCCTGCAGACAGCCCCCGTGCCCATGCCAGACCTGAAGAATGTCAAGT
CCAAGATCGGCTCCACTGAGAACCTGAAGCACCAGCCGGGAGGCGGGAAGGTGCAGATAATTAATAAGAAGCTGGATCTTAGCAAC
GTCCAGTCCAAGTGTGGCTCAAAGGATAATATCAAACACGTCCCGGGAGGCGGCAGTGTGCAAATAGTCTACAAACCAGTTGACCTG
AGCAAGGTGACCTCCAAGTGTGGCTCATTAGGCAACATCCATCATAAACCAGGAGGTGGCCAGGTGGAAGTAAAATCTGAGAAGCTT
GACTTCAAGGACAGAGTCCAGTCGAAGATTGGGTCCCTGGACAATATCACCCACGTCCCTGGCGGAGGAAATAAAAAGATTGAAACC
CACAAGCTGACCTTCCGCGAGAACGCCAAAGCCAAGACAGACCACGGGGCGGAGATCGTGTACAAGTCGCCAGTGGTGTCTGGGG
ACACGTCTCCACGGCATCTCAGCAATGTCTCCTCCACCGGCAGCATCGACATGGTAGACTCGCCCCAGCTCGCCACGCTAGCTGACG
AGGTGTCTGCCTCCCTGGCCAAGCAGGGTTTGTAGATGCCGAAATGCATGTCGAGCTGTATCTGAAACTGAATCTGAAACTGACTCTTTC
TTTGCAAGCTAAGATCAACAAAAGTGAAATATGAGCAGCTAATTTGAAACGTACTATCTAAGCAAAATCCACACAATGCAAAACGAGAGTTA
TGCGATAATTTCCACACACCCAGATAATTCACAAGCCAGTAAATGCGATCAGATCAATTCGATAGAGGTGCAAGCACGCAATGAGATGCAG
ATACTCGTACATCTACACAACCACCCCACATAGAAGCGGTATTTGGTATACAATCGAAAGTATATTTGACTAGTTGAGCAATGCACTCTTTAT
CATCAGATAGCAGACATGAATTATATATCTCAATGTATTACCAGAACTTCATATATACATACAAATCTATATATATATATATATACATATATAAATAAA
AGTATCTAAATATTTAAGCAAATTATACAAGAAACGTACGAATAAAGTGTATGCTTAGTTGAAAATGTTAGTAAACTACGTGTACATAAGCTCA
AAGTAGTTACGTATGATATCTAGAAATTAGCATTAACCCTGATTTATTACTAGACTCTTTATTTGATTAAGAAAGCAACCAAAAGTAATCGATAC
GAGTATATTACAAACATCTATTATCGCTATCCCATTTTGTGTTTACGTCGAGAAATTCATTTTTATGTAATCTGTAATGGTAATCAATTACGTTG
CATTTTCGATTAACACTCATTTATTTTAATATGCAACTAACAGAGCACCACACCCCAAAAGAGGCCCACACAACACCCAAAACACCCAACCA
CCACCCACAGACACGCCCCACCCGAACCGCTTTCAGATAACTCCTACCAACTCCCAAAGATCAATCCGTTTAATGGGGAATTGTGATTATA
AGAACTAACAATTGGACAACGTATTTTGGCACATCTAGGCATCGAATTGTATTTTATTGTGGGCATTCGTGACTTTTATCAGATAGAGCCAC
CGAAATCTTTAGAGATTTGAAACCATCTATGAAGTGTCTAAAAGTATGCTTTGAAAAATAGAAAGTAGCTGCATACCTTTAGACATTTGTTGA
AGTGATTGCAAACCTCTTGAAGTTCCGTAGCTACCATTGATTATTATTTGTTTTTGATTTTAGATGATTTATTGTATTATCTATTGGTTTCTCAG
TTCAATTACACTTACTTTACATTTAAAAATGAATTTCTTTCAAACTCAAACTGAGATTCATTGGCAACAGCGCTTTCCATCTCGAG 
 
HUMAN TAU 2N4R cDNA / K163, 280, 281 and 369 / DROSOPHILA TAU RECONSTITUTION SEQUENCES 
b 
MADVLEKSSLLDAVPPLGDPHPPLPHQQLQQEAAAAAAANAAPPA 
 
PPQQQQPPPHQLQQQQPQQQQLQQKPANARANQDQKEMAEPR 
 
QEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDAGLKESPL 
 
QTPTEDGSEEPGSETSDAKSTPTAEDVTAPLVDEGAPGKQAAAQ 
 
PHTEIPEGTTAEEAGIGDTPSLEDEAAGHVTQARMVSKSKDGTGS 
 
DDKKAKGADGKTKIATPRGAAPPGQKGQANATRIPAKTPPAPKTP 
 
PSSGEPPKSGDRSGYSSPGSPGTPGSRSRTPSLPTPPTREPKKV 
 
AVVRTPPKSPSSAKSRLQTAPVPMPDLKNVKSKIGSTENLKHQPG 
 
GGKVQIINKKLDLSNVQSKCGSKDNIKHVPGGGSVQIVYKPVDLS 
 
KVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNIT 
 
HVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPR 
 
HLSNVSSTGSIDMVDSPQLATLADEVSASLAKQGL 
 
 
DROSOPHILA TAU E1 (82 amino acids) 
HUMAN TAU 2N4R (441 amino acids) 
LYSINES 163, 280, 281 and 369  
 
 
Predicted molecular weight: 54.67 kDa 
Apparent molecular weight on SDS-PAGE: 80 kDa 
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Supplementary Figure-2-Partridge. Amino acid sequence 
of the hTau KI fusion protein. 
	  
Supplementary Figure-3-Partridge. hTau KI proteins were 
expressed in brains of adult flies.  
hTau 
DAPI 
dTau 
DAPI 
tau KO tau KO 
c d 
a b hTau 
DAPI 
dTau 
DAPI 
hTau KI WT 
Supplementary Figure-4-Partridge. Control experiments for 
hTau immunofluorescence on fly embryos. 
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Supplementary Figure-5-Partridge. Neuronal and synaptic 
protein levels were not altered in hTau KI flies. 
Supplementary Figure-6-Partridge. Schematic 
representation of hTau acetylation and phosphorylation 
sites investigated in this study.  
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Supplementary Figure-7-Partridge. hTau mRNA levels were 
comparable in all hTau KI lines. 
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Supplementary Figure-8-Partridge. Imaging of hTau 
expression in hTau-wt, -4Q and -4R embryos and adult 
brains.  
Supplementary Figure-9-Partridge. Mimicking multi-
acetylation altered hTau phosphorylation pattern in 20-day-
old flies.  
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Supplementary Figure-10-Partridge. Evaluation of hTau 
phosphorylation pattern in hTau-wt, hTau-K280Q and hTau-
K280R KI flies. 
Supplementary Figure-11-Partridge. Mimicking multi-
acetylation did not affect hTau solubility 
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Supplementary Figure-12-Partridge. Evaluation of Tubulin 
acetylation in hTau-wt, -4Q and -4R KI flies.  
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Supplementary Figure-13-Partridge. hTau-K280Q KI 
proteins displayed unaltered microtubule-binding properties  
Supplementary Figure-14-Partridge. Evaluation of Aβ  
levels in flies co-expressing Aβ and homozygous hTau-wt, 
-4Q and -4R KI lines.  
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Supplementary figure 15 - Full blots from Figure 1 
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Supplementary figure 17 - Full blots from Figure 5 
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Supplementary figure 18 - blots from Figure 6 
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Supplementary figure 19 - Full blots from Figure 7 
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Supplementary figure 20 - blots from Figure 8 
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SUPPLEMENTARY FIGURE LEGENDS 
  
Supplementary Figure 1. Genomic engineering of the fly tau locus. a. A 
genomic engineering strategy combining ends-out homologous recombination, the 
use of a Cre recombinase and φC31-mediated integration of replacement constructs 
was used to generate the hTau KI lines. Ampr: Ampicilline resistance gene. b. 
Nucleotide sequence of the tau replacement insert used to reconstitute the fly tau 
locus. The hTau 2N4R cDNA is indicated in grey while Drosophila tau sequences are 
shown in purple. The lysine residues investigated in this study are indicated in blue. 
Supplementary Figure 2. Amino acid sequence of the hTau KI fusion protein. 
The hTau 2N4R protein isoform (441 amino acids, grey) is fused to fly tau exon 1 (82 
amino acids, purple). Lysines 163, 280, 281 and 369 are indicated in blue. The hTau 
KI fusion protein has a theoretical MW of 54.67 kDa and runs at the apparent MW of 
80 kDa.  
  
Supplementary Figure 3. hTau KI proteins were expressed in brains of adult 
flies.  a and b. Immunofluorescence for hTau and dTau was performed on brains of 
adult hTau KI (a) and WT (b) flies, respectively, indicating that hTau was localised to 
the nervous system in adult flies. DAPI was used to stain cell nuclei (blue). c and d. 
Immunofluorescence against hTau (c) and dTau (d) proteins was performed in adult 
tau KO control fly brains, showing no Tau immunoreactivity (green) in this line. DAPI 
was used to stain cell nuclei (blue). Scale bar: 100 µm.  
Supplementary Figure 4. Control experiments for hTau immunofluorescence 
on fly embryos. Immunofluorescence on WT (b) and tau KO (c) control embryos 
showed no signal for hTau (green). The htau KI embryo is shown as a positive 
control (a). DAPI was used to stain cell nuclei (blue). Scale bar: 50 µm.  
  
Supplementary Figure 5. Neuronal and synaptic protein levels were not altered 
in hTau KI flies. Expression of neuronal (Elav) and synaptic (Synapsin and 
Syntaxin) proteins was not impaired in 20-day-old hTau KI flies as compared to age-
matched WT controls (p>0.05, Student's t-test). Results were normalised to Actin 
and expressed relative to levels measured in WT flies.  
  
Supplementary Figure 6. Schematic representation of hTau acetylation and 
phosphorylation sites investigated in this study. hTau phosphorylation on S195/
S198/S199/S202 (Tau1, binding to dephosphorylated hTau species) S202/T205 
(AT8), T212/S214 (AT100), S262, and S396/S404 (PHF-1) was analysed following 
pseudo-acetylation or pseudo-deacetylation of hTau at K163, K280, K281 and K369 
(hTau-4Q and hTau-4R, respectively).  
  
Supplementary Figure 7. hTau mRNA levels were comparable in all hTau KI 
lines. hTau mRNA levels were measured by qRT-PCR in fly heads using a probe 
targeting either fly tau exon 1 (a), which is expressed in all investigated lines, or a 
common region on hTau sequence (b). WT flies are shown as a negative control for 
hTau expression. hTau-wt, -4Q and -4R KI flies expressed comparable levels of hTau 
transcripts (p>0.05, one-way ANOVA).   
  
Supplementary Figure 8. Imaging of hTau expression in hTau-wt, -4Q and -4R 
embryos and adult brains. hTau immunofluorescence (green) was performed on 
embryos (left panels) and adult brains (right panels) of hTau-wt, hTau-4Q and 
hTau-4R KI flies. DAPI was used to stain cell nuclei (blue). Scale bars: 100 µm.  
  
Supplementary Figure 9. Mimicking multi-acetylation altered hTau 
phosphorylation pattern in 20-day-old flies. Western blot analysis (a) and 
quantification (b) of hTau phosphorylation (AT8, AT100, anti-pS262-hTau, PHF-1 and 
Tau1 antibodies) and total hTau levels (polyclonal K9JA antibody) retrieved from 
head extracts of 20-day-old hTau-wt, hTau-4Q and hTau-4R KI flies. Results were 
normalized to Tubulin and to total hTau levels and expressed relative to the hTau-wt 
KI line (*p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001, one-way ANOVA followed 
by Tukey’s post hoc test, n=3/genotype). Although total hTau levels retrieved from 
hTau-4Q fly heads appeared lower, imageJ quantification revealed similar hTau 
protein levels among the three mutants (p>0.05, one-way ANOVA), the 
corresponding band being simply more diffuse in hTau-4Q samples.   
  
Supplementary Figure 10. Evaluation of hTau phosphorylation pattern in 2-day-
old hTau-wt, hTau-K280Q and hTau-K280R KI flies. Western blot analysis (a) and 
quantification (b) of hTau phosphorylation (AT8, AT100, anti-pS262-hTau, PHF-1 and 
Tau1 antibodies) and total hTau levels (polyclonal K9JA antibody) retrieved from 
head extracts of 2-day-old hTau-wt, hTau-K280Q and hTau-K280R KI flies. Results 
were normalized to Tubulin and to total hTau levels and expressed relative to the 
hTau-wt KI line (*p<0.05 and ***p<0.001, one-way ANOVA followed by Tukey’s post 
hoc test, n=5/genotype).  
Supplementary Figure 11. Mimicking multi-acetylation did not affect hTau 
solubility. a. Protein extracts from hTau KI fly heads were fractionated into RAB-
soluble and RAB-insoluble/RIPA-1%SDS-soluble fractions and subsequently probed 
with an anti-hTau antibody (K9JA). b. Quantification of the proportion of insoluble 
hTau species observed in fly head extracts from hTau-wt, hTau-4Q and hTau-4R KI 
lines (p>0.05, one-way ANOVA followed by Tukey’s post hoc test, n=4/genotype).  
  
Supplementary Figure 12. Evaluation of Tubulin acetylation in hTau-wt, -4Q 
and -4R KI flies. Western blot analysis indicated that levels of acetylated Tubulin 
retrieved from hTau-wt, hTau-4Q and hTau-4R KI fly heads were comparable 
(p>0.05, one-way ANOVA). Results were normalised to total Tubulin and expressed 
relative to levels measured in hTau-wt KI flies.  
  
Supplementary Figure 13. hTau-K280Q KI proteins displayed unaltered 
microtubule-binding properties. a. In vivo microtubule-binding assay was 
performed on protein extracts from 2-day-old hTau-wt, hTau-K280Q and hTau-K280R 
KI fly heads. Taxol was used to induce microtubule polymerisation, and DMSO, the 
vehicle, was used as a control. S: supernatant, P: pellet. b. Quantification of the 
proportion of microtubule-bound hTau proteins in hTau-wt, hTau-K280Q and hTau-
K280R KI lines, in Taxol conditions. Results are expressed relative to levels 
measured in hTau-wt KI flies (p>0.05, one-way ANOVA followed by Tukey’s post hoc 
test, n=3/genotype).   
  
Supplementary Figure 14.  Aβ levels did not change across the different 
hTauKI lines. Flies co-expressing arctic Aβ42 in combination with any of the 
homozygous hTau-wt, hTau-4Q and hTau-4R KI lines had similar levels of Aβ42 
protein by ELISA analyses, (p>0.05, one-way ANOVA followed by Tukey’s post hoc 
test, n=4/genotype).   
  
Supplementary Figure 15. Full blots from Figure 1. 
  
Supplementary Figure 16. Full blots from Figure 3. 
  
Supplementary Figure 17. Full blots from Figure 5. 
  
Supplementary Figure 18. Full blots from Figure 6. 
  
Supplementary Figure 19. Full blots from Figure 7. 
  
Supplementary Figure 20. Full blots from Figure 8. 
